Yum Brands earnings miss estimates as Pizza Hut, KFC struggle in the U.S.

Yum Brands earnings miss estimates as Pizza Hut, KFC struggle in the U.S.


Piotr Swat | Lightrocket | Getty Images

Yum Brands on Tuesday reported quarterly earnings and revenue that missed analysts’ expectations as Pizza Hut and KFC reported U.S. same-store sales declines.

Here’s what the company reported compared with what Wall Street was expecting, based on a survey of analysts by LSEG:

  • Earnings per share: $1.44 adjusted vs. $1.46 expected
  • Revenue: $1.93 billion vs. $1.94 billion expected

Yum reported second-quarter net income of $374 million, or $1.33 per share, up from $367 million, or $1.28 per share, a year earlier.

Excluding refranchising gains and other items, the company earned $1.44 per share.

Net sales climbed 10% to $1.93 billion.

This story is developing. Please check back for updates.



Source

How Domino’s is trying to double its business during a rough patch for big pizza rivals
Business

How Domino’s is trying to double its business during a rough patch for big pizza rivals

In this photo illustration, a Domino’s pizza sits in a take-out box on July 21, 2025 in Miami, Florida. Joe Raedle | Getty Images Domino’s Pizza shares climbed on a Monday after the company posted a better-than-expected quarter and laid out ambitious growth plans. The strong performance came as the pizza chain said it saw […]

Read More
Mortgage rates just dropped below 6%, matching lowest level since 2022
Business

Mortgage rates just dropped below 6%, matching lowest level since 2022

A stock market sell-off had investors rushing to the relative safety of the bond market Monday morning, causing yields to drop and mortgage rates to follow. The average rate on the popular 30-year fixed mortgage fell to 5.99% on Monday, according to Mortgage News Daily, matching its lowest levels since 2022. Last year at this […]

Read More
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen
Business

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024. Shelby Knowles | Bloomberg | Getty Images Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month’s worth of doses in a single pen. Cash-paying patients can […]

Read More